Back to Journals » OncoTargets and Therapy » Volume 11

RETRACTED ARTICLE: Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway

Authors Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W

Received 11 October 2017

Accepted for publication 13 December 2017

Published 26 February 2018 Volume 2018:11 Pages 983—996

DOI https://doi.org/10.2147/OTT.S153814

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Ingrid Espinoza



This paper has been retracted.

Yang C, Hou A, Yu C, et al. Onco Targets Ther. 2018;11:983-996.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.

Following publication of the article, the authors raised concerns regarding the duplication of images from Figure 3 with images from other articles. In addition, it was also found that images from Figure 6 were also duplicated with images from other articles. Specifically,

  • The image for Figure 3A, HepG2/ADM, 0 µg/mL has been duplicated with the image for Figure 2a, HepG2/ADM, Control from Wang D, Yang C, Wang Z, et al. Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation. Scientific Reports. 2017;9373. https://doi.org/10.1038/s41598-017-09668-2
  • The image for Figure 6D, β-actin, has been duplicated with the image for Figure 6B, PGAM5 from Xu W, Jing L, Wang Q, et al. Bax-PGAM5L-Drp1 complex is required for intrinsic apoptosis execution. Oncotarget. 2015;6:30017-30034. https://www.oncotarget.com/article/5013/text/ and Figure 7d, CTLA-4 from Wang D, et al (2017).

The authors were cooperative and explained the incorrect use of images occurred during figure preparation and the sharing of templates between authors. The authors also provided some of the original data for the study. However, the provided data and the author’s explanation regarding the duplicated images did not sufficiently alleviate the journal’s concerns regarding the validity of the findings. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors agree with this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

Creative Commons License © 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.